Announcements Trials

Browse Landscape

Phase

Phase 2 9 Phase 1/2 3 Phase 1 3 Phase NA 2 Phase 3 2 Phase 4 1 Phase 2/3 1

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Neoplasms 17 Prostatic Neoplasms 14 Lung Neoplasms 12 Carcinoma, Hepatocellular 11 Carcinoma, Non-Small-Cell Lung 10 Multiple Myeloma 9 Colorectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Papillomavirus Infections 6 Pain, Postoperative 6 Neoplasm Metastasis 6 Leukemia, Myeloid, Acute 6 Stomach Neoplasms 5 Recurrence 5 Liver Neoplasms 5 Lymphoma, Non-Hodgkin 4 Kidney Neoplasms 4 Heart Failure 4 Glioma 4 Febrile Neutropenia 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Warts 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Rectal Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3

Interventions

toripalimab 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Nasopharyngeal Neoplasms × Clear all

NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡